These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34714100)

  • 1. HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021.
    Laher F; Richardson SI; Smith P; Sullivan PS; Abrahams AG; Asowata OE; Bitangumutwenzi P; Dabee S; Dollah A; Fernandez N; Langat RK; Bose DL; Likhitwonnawut U; Mullick R; Resop RS; Sutar J; Thompson-Hall AN; Traeger MW; Tuyishime M; Wambui J; Bekker LG; Kaleebu P; McCormack S; O'Connor DH; Warren M; Torri T; Thyagarajan B
    AIDS Res Hum Retroviruses; 2022 May; 38(5):350-358. PubMed ID: 34714100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights.
    Shacklett BL; Derdeyn CA; Folayan MO; Landovitz RJ; Anthony C; Behrens AJ; Hope TJ; Landais E; Leal L; Marrazzo JM; Morris L; Mugo N; Ngure K; Noseda V; Ranasinghe S; Tully DC; Voronin Y; Warren M; Wibmer CK; Xie IY; Scarlatti G; Thyagarajan B
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):749-759. PubMed ID: 28649869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV Research for Prevention 2018: From Research to Impact Conference Summary and Highlights.
    Shacklett BL; Blanco J; Hightow-Weidman L; Mgodi N; Alcamí J; Buchbinder S; Chirenje M; Dabee S; Diallo M; Dumchev K; Herrera C; Levy ME; Martin Gayo E; Makoah NA; Mitchell KM; Mugwanya K; Reddy K; Rodríguez ML; Rodriguez-Garcia M; Shover CL; Shrivastava T; Tomaras G; Van Diepen M; Walia M; Warren M; Manrique A; Thyagarajan B; Torri T
    AIDS Res Hum Retroviruses; 2019 Jul; 35(7):598-607. PubMed ID: 31007035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Public Health Implications of Adapting HIV Pre-exposure Prophylaxis Programs for Virtual Service Delivery in the Context of the COVID-19 Pandemic: Systematic Review.
    Patel P; Kerzner M; Reed JB; Sullivan PS; El-Sadr WM
    JMIR Public Health Surveill; 2022 Jun; 8(6):e37479. PubMed ID: 35486813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "These Girls Have a Chance to be the Future Generation of HIV Negative": Experiences of Implementing a PrEP Programme for Adolescent Girls and Young Women in South Africa.
    Duby Z; Bunce B; Fowler C; Jonas K; Bergh K; Govindasamy D; Wagner C; Mathews C
    AIDS Behav; 2023 Jan; 27(1):134-149. PubMed ID: 35793053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV research in South Africa: Advancing life.
    Gray G; Doherty T; Mohapi L; Coetzee J; Hopkins KL; Malahleha M; Lazarus E; Dietrich J; Pillay-van Wyk V; Laher F
    S Afr Med J; 2019 Dec; 109(11b):36-40. PubMed ID: 32252866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.
    Rosen JG; Zhang L; Pelaez D; Coleman JS; To C; Cooper L; Olatunde PF; Toomre T; Glick JL; Park JN
    AIDS Patient Care STDS; 2022 Aug; 36(8):313-320. PubMed ID: 35951445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
    Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
    J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highlights of HIVR4P // Virtual.
    Harris P; Henderson R
    Lancet HIV; 2021 Mar; 8(3):129. PubMed ID: 33662260
    [No Abstract]   [Full Text] [Related]  

  • 10. Scaling up pre-exposure prophylaxis in sub-Saharan Africa.
    Ahmed N; Pike C; Bekker LG
    Curr Opin Infect Dis; 2019 Feb; 32(1):24-30. PubMed ID: 30461452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions.
    McNicholl JM
    Hum Vaccin Immunother; 2016 Dec; 12(12):3202-3211. PubMed ID: 27679928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries.
    Kerzner M; De AK; Yee R; Keating R; Djomand G; Stash S; Rana S; Kimmel A; Eakle R; Klucking S; Patel P;
    PLoS One; 2022; 17(4):e0266280. PubMed ID: 35381024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches.
    Brown JL; Sales JM; DiClemente RJ
    Curr HIV/AIDS Rep; 2014 Dec; 11(4):363-75. PubMed ID: 25216985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily Oral Pre-exposure Prophylaxis (PrEP) Continuation Among Women from Durban, South Africa, Who Initiated PrEP as Standard of Care for HIV Prevention in a Clinical Trial.
    Beesham I; Joseph Davey DL; Beksinska M; Bosman S; Smit J; Mansoor LE
    AIDS Behav; 2022 Aug; 26(8):2623-2631. PubMed ID: 35122575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Prescriptions in the United States-A Time-Series Analysis.
    Huang YLA; Zhu W; Wiener J; Kourtis AP; Hall HI; Hoover KW
    Clin Infect Dis; 2022 Aug; 75(1):e1020-e1027. PubMed ID: 35040928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Perspectives on the Determinants of Acceptability of Pre-Exposure Prophylaxis and Nonoccupational Post-Exposure Prophylaxis among People at Risk for HIV: A Scoping Review.
    Zhou L; Assanangkornchai S
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36231904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
    Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
    AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the Impact of COVID-19 on Pre-Exposure Prophylaxis (PrEP) Care.
    Rogers BG; Tao J; Maynard M; Chu C; Silva E; Toma E; Nagel K; Napoleon S; Chan PA
    AIDS Behav; 2021 Nov; 25(11):3754-3757. PubMed ID: 34114166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-Exposure Prophylaxis (PrEP) Uptake among Black Men Who Have Sex with Men (BMSM) in the Southern U.S.
    Adeagbo O; Harrison S; Qiao S; Li X
    Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual CROI 2020: Highlights of Epidemiology, Public Health, and Prevention Research.
    Buchbinder SP; Liu AY
    Top Antivir Med; 2020 Jun; 28(2):439-454. PubMed ID: 32886464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.